Acute Antibody-mediated Rejection 1 Week After Lung Transplantation Successfully Treated With Eculizumab, Intravenous Immunoglobulins, and Rituximab.

Details

Ressource 1Download: 29521880_pp_cover.pdf (493.82 [Ko])
State: Public
Version: Author's accepted manuscript
Serval ID
serval:BIB_A55614976F55
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Acute Antibody-mediated Rejection 1 Week After Lung Transplantation Successfully Treated With Eculizumab, Intravenous Immunoglobulins, and Rituximab.
Journal
Transplantation
Author(s)
Muller Y.D., Aubert J.D., Vionnet J., Rotman S., Sadallah S., Aubert V., Pascual M.
ISSN
1534-6080 (Electronic)
ISSN-L
0041-1337
Publication state
Published
Issued date
06/2018
Peer-reviewed
Oui
Volume
102
Number
6
Pages
e301-e303
Language
english
Notes
Publication types: Case Reports ; Letter ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Keywords
Antibodies, Monoclonal, Humanized/therapeutic use, Drug Therapy, Combination, Female, Graft Rejection/diagnosis, Graft Rejection/drug therapy, Graft Rejection/immunology, Graft Survival/drug effects, Humans, Immunoglobulins, Intravenous/therapeutic use, Immunosuppressive Agents/therapeutic use, Isoantibodies/immunology, Lung Transplantation/adverse effects, Middle Aged, Rituximab/therapeutic use, Time Factors, Treatment Outcome
Pubmed
Web of science
Create date
13/03/2018 10:34
Last modification date
20/08/2019 16:10
Usage data